OWL and Biosfer join forces to reinforce metabolomics in the diagnosis and treatment of illness

The two companies, representatives of diagnosis solutions based on metabolomic technology, have signed a collaboration agreement to strengthen R&D in the sector. The Basque biotechnology firm OWL will contribute know-how in the creation of non-invasive diagnosis solutions for Non-Alcoholic Steatohepatitis (NASH). The goal is to encourage the use of metabolomic technology in the research and…